✅ Improved Speech and Communication
 A clinical trial found that LLLT combined with neurorehabilitation improved language, cognitive, and social skills in children with autism.
 🔗 Lights on for Autism – PMC Study

✅ Calmer Behavior and Fewer Meltdowns
 A follow-up study six months after LLLT concluded children showed sustained reductions in irritability and behavioral outbursts.
 🔗 Follow-Up Assessment Study

✅ Better Focus and Emotional Regulation
 A retrospective study found transcranial photobiomodulation significantly improved behavior regulation, attention, and mood in children with ASD.
 🔗 MDPI Study: Children, 2022

✅ Stronger Sensory Processing and Reduced Anxiety
 Clinical data supports LLLT’s effect in modulating sensory systems and activating calming pathways, leading to reduced anxiety and improved tolerance to stimuli.
 🔗 PubMed Research

✅ Clinically Proven Results for Autism Therapy
 A quadruple-blind FDA-submitted study showed statistically significant improvements in children with autism using Erchonia’s low-level laser technology.
 🔗 Erchonia FDA Study Overview

Effects of Low-Level Laser Therapy in Autism Spectrum Disorder                                                                                                                                 This study found that LLLT could be an effective tool for reducing irritability and other symptoms associated with autism spectrum disorder in children and adolescents, with positive changes maintained and augmented over time.
🔗PubMed

Transcranial Photobiomodulation in Children Aged 2–6 Years with Autism Spectrum Disorder
A randomized, sham-controlled clinical trial involving children with autism spectrum disorder, delivering near-infrared light noninvasively to selected brain areas, aiming to assess the therapy's efficacy.

🔗Frontiers

Advances in photobiomodulation for cognitive improvement by near-infrared derived multiple strategies

🔗NIH